产品中心

产品中心

>
>
>
Novel coronavirus (2019-nCoV) lgM/lgG antibody detection kit
Novel coronavirus (2019-nCoV) lgM/lgG antibody detection kit
Novel coronavirus (2019-nCoV) lgM/lgG antibody detection kit
Novel coronavirus (2019-nCoV) lgM/lgG antibody detection kit
High-throughput plasma nano-biochip detection technology (pGOLD)
contact us
product description

Shenzhen Wuweihuasi Biological Technology Co., Ltd. is a high-tech enterprise incubated by the fourth batch of Shenzhen Peacock team "plasma nano biochip technology innovation team" of Shenzhen Tsinghua University Research Institute. The company is located in the national biomedical industry in Pingshan District, Shenzhen base. The company’s R&D team brings together experts and scholars from internationally renowned universities such as Stanford University, Lawrence National Laboratory, Peking University, Shanghai Jiaotong University, Southern University of Science and Technology, etc. The team’s R&D members are engaged in biochip development, nanomaterial preparation, nanotechnology The research and development of technology in biological detection applications and other fields is at the international leading level.

The company’s near-infrared fluorescence-enhanced high-sensitivity, high-throughput plasma nano-biochip detection technology (pGOLD) is an international leader and can achieve multi-index non-invasive, minimally invasive and precise detection. It is an in vitro diagnostic reagent product field. Revolutionary results. The developed infrared fluorescent POCT detection product (IR-LF) based on infrared fluorescent nanospheres can realize rapid and accurate quantitative detection of diseases. It is a breakthrough achievement in the field of POCT products and is an international initiative. The immunization production line based on the two major platform technologies can not only provide the best immunization testing for more than 10,000 tertiary hospitals and nearly 70,000 primary medical institutions in my country, but also can connect to the global innovative testing projects. Compared with the world's mainstream technology platforms, the company's two core technology platforms are internationally advanced, which can effectively solve the current technical problems of precise quantification and sensitivity in the field of rapid disease detection, and have the potential to become leading products.

  • imgE-mail:

    Info@wwhsbio.com

  • imgTEL:

    0755 - 84235529

  • imgADD:
qr

Pay attention to our

关注我们

CopyRight @ 2020  Shenzhen Weihua Biological Technology Co., LTD      粤ICP备17047630